Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.290
-0.070 (-5.15%)
At close: Jun 5, 2026, 4:00 PM EDT
1.350
+0.060 (4.65%)
After-hours: Jun 5, 2026, 7:59 PM EDT
Cognition Therapeutics Employees
Cognition Therapeutics had 14 employees as of December 31, 2025. The number of employees decreased by 14 or -50.00% compared to the previous year.
Employees
14
Change (1Y)
-14
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$1,398,357
Market Cap
115.27M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 14 | -14 | -50.00% | 14 | 0 |
| Dec 31, 2024 | 28 | 0 | - | 25 | 3 |
| Dec 31, 2023 | 28 | 3 | 12.00% | 25 | 3 |
| Dec 31, 2022 | 25 | 4 | 19.05% | 22 | 3 |
| Dec 31, 2021 | 21 | 1 | 5.00% | 19 | 2 |
| Sep 30, 2021 | 18 | -2 | -10.00% | 15 | 3 |
| Jun 30, 2021 | 22 | - | - | 18 | 4 |
| Mar 31, 2021 | 22 | - | - | 20 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fractyl Health | 100 |
| Alps Group | 93 |
| enGene Therapeutics | 82 |
| Verrica Pharmaceuticals | 76 |
| Alpha Cognition | 71 |
| Pyxis Oncology | 56 |
| TuHURA Biosciences | 22 |
| Black Diamond Therapeutics | 21 |
CGTX News
- 3 days ago - Cognition Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 3 days ago - Cognition Therapeutics Slides: Investor presentation - Filings
- 6 days ago - Cognition Therapeutics Participating in Upcoming Investor Conferences - GlobeNewsWire
- 17 days ago - Cognition Therapeutics conducts zervimesine meeting with FDA - TheFly
- 17 days ago - Cognition Therapeutics Completes Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies with Psychosis - GlobeNewsWire
- 24 days ago - Cognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies - GlobeNewsWire
- 4 weeks ago - Cognition Therapeutics reports Q1 EPS (5c), consensus (7c) - TheFly
- 4 weeks ago - Cognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update - GlobeNewsWire